Ignite Creation Date:
2025-12-24 @ 10:35 PM
Ignite Modification Date:
2026-01-25 @ 12:11 AM
Study NCT ID:
NCT00129935
Status:
COMPLETED
Last Update Posted:
2023-03-31
First Post:
2005-08-11
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
EC Followed Docetaxel Versus ET Followed Capecitabine as Adjuvant Chemotherapy for Node Positive Operable Breast Cancer
Sponsor:
Spanish Breast Cancer Research Group
Organization: